Prognostic value of plasminogen activator inhibitor‐1 in biomarker exploration using multiplex immunoassay in patients with metastatic renal cell carcinoma treated with axitinib

BACKGROUND AND AIMS: Vascular endothelial growth factor‐directed therapies play a significant role in patients with metastatic renal cell carcinoma (mRCC). Biomarkers for predicting treatment efficacy and resistance are required to develop personalized medicine. We evaluated multiple serum cytokine...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Health Sci Rep
Main Authors: Honma, Naoko, Inoue, Takamitsu, Tsuchiya, Norihiko, Koizumi, Atsushi, Yamamoto, Ryohei, Nara, Taketoshi, Kanda, Sohei, Huang, Mingguo, Numakura, Kazuyuki, Saito, Mitsuru, Narita, Shintaro, Satoh, Shigeru, Habuchi, Tomonori
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7559632/
https://ncbi.nlm.nih.gov/pubmed/33088925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hsr2.197
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados